Full Text View
Tabular View
No Study Results Posted
Related Studies
Drug Therapy in Lupus Nephropathy
This study has been completed.
Study NCT00001212   Information provided by National Institutes of Health Clinical Center (CC)
First Received: November 3, 1999   Last Updated: April 8, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Nephrotic Syndrome
Systemic Lupus Erythematosus
Additional conditions recognized in this trial
Lupus Erythematosus, Systemic
Syndrome
More general conditions related to this trial
Autoimmune Diseases
Connective Tissue Diseases
Disease
Immune System Diseases
Kidney Diseases
Nephrosis
Pathologic Processes
Urologic Diseases
Interventions listed in this trial
prednisone
cyclophosphamide
cyclosporin A
Additional drug interventions recognized in this trial
Cyclosporine
Cyclosporins
Immunosuppressive Agents
More general drug interventions related to this trial
Alkylating Agents
Anti-Infective Agents
Anti-Inflammatory Agents
Antifungal Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antineoplastic Agents, Hormonal
Antirheumatic Agents
Dermatologic Agents
Enzyme Inhibitors
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Immunologic Factors
Molecular Mechanisms of Pharmacological Action
Myeloablative Agonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services